352534-95-3
352534-95-3
Chemical Structure
PIPES-d18
Synonym(s): 1,4-Piperazinediethanesulfonic acid-d18
- CAS No.: 352534-95-3
- Formula:C8D18N2O6S2
- Molecular Weight:320.48
IUPAC Name: 2,2'-(piperazine-1,4-diyl-d8)bis(ethane-1-sulfonic-1,1,2,2-d4 acid-d)
InChIKey: IHPYMWDTONKSCO-SVSBSETCSA-N
SMILES: O=S(C([2H])([2H])C([2H])([2H])N1C([2H])([2H])C([2H])([2H])N(C([2H])([2H])C1([2H])[2H])C([2H])([2H])C([2H])([2H])S(=O)(O[2H])=O)(O[2H])=O
Biological Activity: PIPES-d18 is the deuterium labeled PIPES[1]. PIPES (1,4-Piperazinediethanesulfonic acid) is an important component of PIPES buffer agent used in biochemistry[2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PIPES-d18 | 98.0% | PIPES-d18 is the deuterium labeled PIPES. PIPES (1,4-Piperazinediethanesulfonic acid) is an important component of PIPES buffer agent used in biochemistry. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
PIPES | 98.0% | PIPES (1,4-Piperazinediethanesulfonic acid) is an important component of PIPES buffer agent used in biochemistry. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.88
HY-W011271PIPES monosodium -
Similarity Score 0.85
HY-W342700PIPPS -
Similarity Score 0.81
HY-W509915PIPBS -
Similarity Score 0.80
HY-W040147PIPES disodium -
Similarity Score 0.80
HY-W327886PIPES dipotassium -
Similarity Score 0.78
HY-D0873HEPPS -
Similarity Score 0.77
HY-108535RHEPES sodium (Standard) -
Similarity Score 0.76
HY-W105704HEPBS -
Similarity Score 0.72
HY-D0876POPSO,99% with 2H2O -
Explore the MedChemAI to find more analogs
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [Content Brief]
- [2]. Jason Moggridge, et al. Sensitive Detection of Immunoglobulin G Stability Using in Real-Time Isothermal Differential Scanning Fluorimetry: Determinants of Protein Stability for Antibody-Based Therapeutics. Technol Cancer Res Treat. 2017 Dec;16(6):997-1005. [Content Brief]
